IP Library › Assignment 013943/0249
Patent Assignment
Reel/Frame 013943/0249

Assignment of Assignor's Interest

Recorded: 2003-04-08 Pages: 5
Assignor
CENES PHARMACEUTICALS, INC.
Executed: 2003-02-28
Assignee
ACORDA THERAPEUTICS, INC.
15 SKYLINE DRIVE, HAWTHORNE, NEW YORK, 10532
Covered Properties (28)
Dna Encoding Glial Mitogenic Factors
Patent: 5,530,109 →
Application: 08/036,555 →
Glial Growht Factors
Patent: 5,716,930 →
Application: 08/249,322 →
Schwann Cell Mitogenic Factor, Its Preparation and Use
Patent: 5,594,114 →
Application: 08/311,365 →
Use of Neuregulins as Modulators of Cellular Communication
Patent: 6,087,323 →
Application: 08/341,018 →
Methods of Treating Disorders of the Eye
Patent: 6,750,196 →
Application: 08/411,295 →
Methods for Treating Muscle Diseases and Disorders
Patent: 7,037,888 →
Application: 08/461,097 →
Methods of Increasing Myotube Formaton or Survival or Muscle Cell Mitogenesis, Differentiation or Survival Using a Neuregulin
Patent: 6,444,642 →
Application: 08/467,602 →
Methods for Treating Muscle Diseases and Disorders
Patent: 7,384,756 →
Application: 08/468,731 →
Glial Mitogenic Factors, Their Preparation and Use
Patent: 5,792,849 →
Application: 08/469,526 →
Glial Mitogenic Factors, Their Preparation and Use
Patent: 5,606,032 →
Application: 08/469,569 →
Method for Making Antibodies Which Specifically Bind to Glial Growth Factors
Patent: 5,876,973 →
Application: 08/469,660 →
Glial Mitogenic Factors, Their Preparation and Use
Patent: 6,147,190 →
Application: 08/470,335 →
Methods of Stimulating Mitogensis in Glial Cells Using Glial Mitogenic Factors
Patent: 6,232,286 →
Application: 08/470,339 →
Glial Mitogenic Factors, Their Preparation and Use
Patent: 7,135,456 →
Application: 08/471,833 →
Glial Mitogenic Factors
Patent: 5,621,081 →
Application: 08/471,855 →
Method of Using a Secretable Glial Mitogenic Factor to Induce Acetylch Oline Receptor Synthesis
Patent: 5,602,096 →
Application: 08/472,008 →
Method for Prophylaxis or Treatment of a Nervous System, Pathophysiological Condition Involving a Glial Growth Factor Sensitive Cell by Administration of a Glial Growth Factor
Patent: 7,285,531 →
Application: 08/472,065 →
Process for Preparing a Ziegler-Type Spherical Catalyst for Alpha-Olefin Polymerization, Spherical Catalyst, Process for Preparing a Spherical Polyethylene of Ultra-High Molecular Weight and Spherical Polyethylene of Ultra-High Molecular Weight
Application: 08/730,019 →
Glial Mitogenic Factors, Their Preparation and Use
Patent: 5,854,220 →
Application: 08/734,591 →
Glial Mitogenic Factors, Their Preparation and Use
Patent: 7,094,749 →
Application: 08/734,592 →
Methods for Treating Nervous System Pathophysiologies Using Glial Glial Growth Factors
Patent: 6,204,241 →
Application: 08/734,664 →
Glial Mitogenic Factors Lacking an N-Terminal Signal Sequence
Patent: 7,319,019 →
Application: 08/734,665 →
Methods for Treating Multiple Sclerosis with Ggf-Related Polypeptides
Patent: 7,192,915 →
Application: 08/735,010 →
Glial Mitogenic Factors, Their Preparation and Use
Patent: 6,194,377 →
Application: 08/735,021 →
Methods for Inducing Myelination Using Glial Growth Factors
Patent: 6,972,280 →
Application: 08/736,019 →
Publication: US 2003/0207799
Method for Treating Congestive Heart Failure
Patent: 6,635,249 →
Application: 09/298,121 →
Neuregulins as Modulators of Cellular Communication
Application: 09/366,886 →
Publication: US 2003/0040465
Therapeutic methods comprising use of a neuregulin
Application: 09/530,884 →
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 26, 1993
From: MARCHIONI, MARK; CHEN, MARIO S.
To: CAMBRIDGE NEUROSCIENCE
Reel/Frame 006556/0261 →
Assignment of Assignor's Interest May 26, 1993
From: GOODEARL, ANDREW; STROOBANT, PAUL; MINGHETTI, LUISA; WATERFIELD, MICHAEL
To: LUDWIG INSTITUTE FOR CANCER RESEARCH
Reel/Frame 006556/0263 →
Assignment of Assignor's Interest Sep 19, 1994
From: GOODEARL, ANDREW DAVID; STROOBANT, PAUL; MINGHETTI, LUISA; WATERFIELD, MICHAEL
To: LUDWIG INSTITUTE FOR CANCER RESEARCH
Reel/Frame 007217/0364 →
Assignment of Assignor's Interest Sep 19, 1994
From: HILES, IAN
To: LUDWIG INSTITUTE FOR CANCER RESEARCH
Reel/Frame 007217/0362 →
Assignment of Assignor's Interest Sep 19, 1994
From: MARCHIONNI, MARK; CHEN, MAIO SU
To: CAMBRIDGE NEUROSCIENCE
Reel/Frame 007217/0360 →
Assignment of Assignor's Interest Apr 10, 1995
From: GWYNNE, DAVID I.; MAHANTHAPPA, NAGESH K; MARCHIONNI, MARK A.; BERMINGHAM-MCDONOGH, OLIVIA
To: CAMBRIDGE NEUROSCIENCE, LNC.
Reel/Frame 007458/0429 →
Assignment of Assignor's Interest Mar 25, 1996
From: MARCHIONNI, MARK A.; BERMINGHAM-MCDONOGH, OLIVIA; MAHANTHAPPA, NAGESH K.; GWYNNE, DAVID I.
To: CAMBRIDGE NEUROSCIENCE, INC.
Reel/Frame 008069/0250 →
Assignment of Assignor's Interest Mar 25, 1996
From: REH, THOMAS A.; MCCABE, KATHRYN L.
To: UNIVERSITY OF WASHINGTON
Reel/Frame 008069/0207 →
Assignment of Assignor's Interest May 17, 1996
From: KAWAKUBO, YOUICHI; KAWAMURA, YOSHIO; SEO, YOSUKE
To: HITACHI, LTD.
Reel/Frame 007944/0438 →
Confirmatory License Jun 17, 1997
From: WASHINGTON, UNIVERSITY OF
To: NATIONAL INSTITUTES OF HEALTH, THE
Reel/Frame 008597/0695 →
Assignment of Assignor's Interest Dec 22, 1998
From: GOODEARL, ANDREW; STROOBANT, PAUL; MINGHETTI, LUISA; WATERFIELD, MICHAEL
To: LUDWIG INSTITUTE OF CANCER RESEARCH
Reel/Frame 009669/0174 →
Assignment of Assignor's Interest Dec 22, 1998
From: CHEN, MARIO SU; MARCHIONI, MARK
To: CAMBRIDGE NEUROSCIENCE, INC.
Reel/Frame 009669/0202 →
Change of Name May 21, 2001
From: CAMBRIDGE NEUROSCIENCE, INC.
To: CENES PHARMACEUTICALS, INC.
Reel/Frame 011812/0784 →
Security Interest Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →
Confirmatory License Nov 14, 2016
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 040305/0188 →
Release of Security Interest May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →